FOXL2 Gene Blepharophimosis epicanthus inversus and ptosis Genetic Test
At DNA Labs UAE, we offer the FOXL2 Gene Blepharophimosis epicanthus inversus and ptosis Genetic Test. This test is designed to identify mutations in the FOXL2 gene, which is associated with a condition called blepharophimosis, epicanthus inversus, and ptosis (BEP). BEP is characterized by droopy eyelids (ptosis), narrow eye openings (blepharophimosis), and inwardly turned eyelids (epicanthus inversus).
The FOXL2 Gene Blepharophimosis epicanthus inversus and ptosis Genetic Test can be performed using a blood sample, extracted DNA, or even just one drop of blood on an FTA card. Our advanced NGS (Next-Generation Sequencing) technology allows for accurate and efficient testing.
Our dedicated team of ophthalmologists and geneticists will analyze the test results and provide a comprehensive report. The report will be delivered within 3 to 4 weeks, ensuring a prompt diagnosis.
Before undergoing the FOXL2 Gene Blepharophimosis epicanthus inversus and ptosis Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the condition. This information will help in the interpretation of the test results and provide valuable insights for family planning.
Early diagnosis and treatment of BEP is crucial in preventing vision problems and improving the quality of life for affected individuals. Treatment options may include surgery to correct ptosis or blepharophimosis, as well as the use of corrective lenses for vision problems.
At DNA Labs UAE, we understand the importance of accurate and timely genetic testing. Our FOXL2 Gene Blepharophimosis epicanthus inversus and ptosis Genetic Test can provide the necessary information for diagnosis and treatment planning. Contact us today to schedule an appointment.
Test Name: FOXL2 Gene Blepharophimosis epicanthus inversus and ptosis Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Test Type: Ophthalmology Disorders
Doctor: Ophthalmologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for FOXL2 Gene Blepharophimosis, epicanthus inversus, and ptosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FOXL2 Gene Blepharophimosis, epicanthus inversus, and ptosis NGS Genetic DNA Test gene FOXL2
Test Name | FOXL2 Gene Blepharophimosis epicanthus inversus and ptosis Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ophthalmology Disorders |
Doctor | Ophthalmologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for FOXL2 Gene Blepharophimosis, epicanthus inversus, and ptosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FOXL2 Gene Blepharophimosis, epicanthus inversus, and ptosis NGS Genetic DNA Test gene FOXL2 |
Test Details | The FOXL2 gene is associated with a condition called blepharophimosis, epicanthus inversus, and ptosis (BEP), which is characterized by droopy eyelids (ptosis), narrow eye openings (blepharophimosis), and inwardly turned eyelids (epicanthus inversus). NGS genetic testing can identify mutations in the FOXL2 gene, which can confirm a diagnosis of BEP and help with genetic counseling and family planning. Early diagnosis and treatment of BEP can prevent vision problems and improve quality of life. Treatment options may include surgery to correct ptosis or blepharophimosis, and corrective lenses for vision problems. |